#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma multiforme Mantle cell lymphoma stage II Pericarditis Retinal artery occlusion Germ cell cancer Ependymoma Hereditary haemorrhagic telangiectasia Transitional cell cancer of the renal pelvis and ureter Mucopolysaccharidosis III Peripheral primitive neuroectodermal tumour of soft tissue Dementia Metastases to peritoneum Leiomyosarcoma recurrent Small cell lung cancer limited stage Extra-osseous Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Diagnostics Hepatoblastoma – Treatment Alagille syndrome Chordoma – Trials in Disease Optic glioma – Life with Disease Familial amyotrophic lateral sclerosis – Life with Disease Hypereosinophilic syndrome Mucopolysaccharidosis II – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Castleman’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Specific Nucleic Acid Sna-Papi Rozanolixizumab Wve-006 Mometasone Ucp2 Glipizide Ptg-Carcik-Cd19 Romosozumab Carbamazepine Msv-Allo Edg-5506 Sulfur Hexafluoride Quercus Ilex Allergen Extract Al8326 Dinoprostone TUVATEXIB Selgantolimod Resamirigene Bilparvovec Regn9933 Gsk6097608 More therapies…

    Learn about Your Condition

    Malignant oligodendroglioma Hypertrophic cardiomyopathy Head and neck cancer Perthes disease Non-small cell lung cancer Chondropathy Cryoglobulinaemia Lymphoma Paraganglion neoplasm Aortic disorder Tympanic membrane perforation Post procedural hypotension Autoimmune disorder Brain abscess Colorectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pouchitis

  • Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Guselkumab
    Belgium

  • Study on GM-CSF, Fosfomycin, and Metronidazole for Treating Pouchitis in Ulcerative Colitis Patients Post-Surgery

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Fosfomycin
    • Molgramostim
    • Metronidazole
    Denmark

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Ciprofloxacin Hydrochloride
    • Ciprofloxacin
    Belgium Croatia Czechia Denmark Greece Italy +2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!